Knowstox

Fundamentals snapshot

InnovAge Holding Corp.

INNV · NMS · Healthcare · Medical Care Facilities

Current price

$10.85

52-week range

$3.94 - $12.64

Market cap

$1.48B

One-glance verdict

Within fair range

$12.96 our estimate vs market $10.85

Wall Street consensus: $10.50 (-19.0% lower than our fair-value estimate)

Balance sheet

Healthy

1.36x Concerning

Net cash $54.38M. Interest coverage shows how many times profit covers the interest bill.

What this company does

InnovAge Holding Corp.

InnovAge provides a complete package of healthcare and support services to older adults, helping them live at home instead of moving into a nursing home. The company makes its money from fixed monthly payments from government programs for each person it cares for, which creates a steady and predictable income stream. This model is important because it allows the company to focus on preventative care to keep seniors healthy and costs down over the long term.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2025 Q1 $-9.72M FY2025 Q2 $5.41M FY2025 Q3 $21.73M FY2025 Q4 $8.82M FY2026 Q1 $-153.00K FY2026 Q2 $19.00M FY2026 Q3 $14.54M FY2026 Q4 $17.02M
Revenue $261.95M
Net income $8.29M
Diluted EPS 0.06
Operating cash flow $21.29M
Free cash flow $17.02M
Revenue $251.94M
Net income $-29.46M
Diluted EPS -0.22
Operating cash flow $18.14M
Free cash flow $14.54M
Revenue $239.71M
Net income $10.62M
Diluted EPS 0.08
Operating cash flow $21.36M
Free cash flow $19.00M
Revenue $236.10M
Net income $8.02M
Diluted EPS 0.06
Operating cash flow $3.92M
Free cash flow $-153.00K
Revenue $221.42M
Net income $-785.00K
Diluted EPS 0.00
Operating cash flow $9.00M
Free cash flow $8.82M
Revenue $218.14M
Net income $-11.38M
Diluted EPS -0.08
Operating cash flow $24.63M
Free cash flow $21.73M
Revenue $209.00M
Net income $-13.22M
Diluted EPS -0.10
Operating cash flow $6.75M
Free cash flow $5.41M
Revenue $205.14M
Net income $-4.93M
Diluted EPS -0.04
Operating cash flow $-7.52M
Free cash flow $-9.72M

Is it cheap or expensive?

Fair value $12.96 vs current price $10.85

Wall Street consensus is the average analyst price target: $10.50 (-19.0% lower than our fair-value estimate).

Our most-likely fair value is $12.96 a share — about 19.5% away from today's price of $10.85, so the stock currently looks fairly priced.

fair

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 10.0% · Discount 7.2% · Terminal 2.5%

$12.96

Bear

Growth 5.0% · Discount 7.2% · Terminal 2.5%

$9.78

Bull

Growth 16.0% · Discount 7.2% · Terminal 2.5%

$18.08

Is it drowning in debt?

Healthy

Net cash $54.4M - more cash than debt. Interest coverage 1.4x.

Net debt $-54.38M
Interest coverage 1.36x

InnovAge Holding Corp.'s profit covers its interest bill about 1.4 times over. which is weaker than most peers shown here.

Healthy
Worse cushion Baseline Better cushion
INNV BASELINE InnovAge Holding Corp.

Total debt $86.95M Interest coverage 1.36x This is the baseline the peer rows are being compared against.

Total debt $108.82M Interest coverage 10.18x +651% vs INNV Carries about 7.5x more debt cushion than INNV.

Total debt $1.51B Interest coverage 1.94x +43% vs INNV Carries about 1.4x more debt cushion than INNV.

Total debt $1.27B Interest coverage 6.19x +357% vs INNV Carries about 4.6x more debt cushion than INNV.

Total debt $2.25B Interest coverage 53.24x +3,828% vs INNV Carries about 39.3x more debt cushion than INNV.

What you should know

The case for and against INNV

2 Rewards 1 Risk

Rewards

  • Revenue grew 15.9% last year.
  • Free cash flow was positive in 2/10 years.

Risks

  • Return on equity was -0.3% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
Forward P/E
21.70x
P/B
6.26x
P/S
1.50x
EV/EBITDA
54.37x
PEG ratio

Profitability

How much profit each dollar creates

Gross margin
68.5%
Operating margin
5.0%
Net margin
-0.3%
ROE
-0.3%
ROA
0.7%

Health

Liquidity and balance-sheet strength

Debt / equity
0.32x
Current ratio
1.05x
Quick ratio
0.92x
Total debt
$86.95M
Total cash
$141.33M

Growth

How the business has been compounding

Revenue TTM
$989.71M
Revenue 5Y CAGR
9.1%
EPS TTM
-0.02
EPS 5Y CAGR

Cash flow

How much cash the business throws off

Operating CF TTM
$64.71M
Free CF TTM
$50.41M
FCF margin
5.1%

Dividend

Shareholder payout

Yield
Payout ratio
0.0%
Last ex-div date